Unlimited access to care: Effect on racial disparity and prognostic factors in lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 25-31

  Mulligan, Charles R ^a   Meram, Amir D ^a,b   Proctor, Courtney D ^b   Wu, Hongyu ^a   Zhu, Kangmin ^a   Marrogi, Aizen J ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER SURVIVAL; CIGARETTE SMOKING; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HUMAN; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; TREATMENT OUTCOME; ADENOCARCINOMA; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; FOLLOW UP; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; STATISTICS; SURVIVAL; SURVIVAL RATE; UNITED STATES;

ADENOCARCINOMA; AFRICAN AMERICANS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 33645461413     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0537     Document Type: Review

References (37)

1. SEER cancer review 1975-2001. National Cancer Institute: Bethesda (MD). 2004.
2. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-57.
3. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Lung carcinoma symptoms: an independent predictor survival and an important mediator of African American disparity in survival. Cancer 2004;101:1655-66.
4. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender, and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004;57:597-609.
5. Ebbert JO, Williams BA, Sun Z, et al. Duration of smoking abstinence as a predictor for non-small cell lung cancer survival in women. Lung Cancer 2005;47:165-72.
6. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer 1996;77:1947-55.
7. Ries LA. Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 1994;10:21-30.
8. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 1988;88:1681-4.
9. Mayne ST, Buenconsejo J, Janerich DT. Familial cancer history and lung cancer risk in United States non-smoking men and women. Cancer Epidemiol Biomarkers Prev 1999;8:1065-9.
10. Gail MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group. Cancer 1984;54:1802-13.
11. Clee MD, Hockings NF, Johnston RN. Bronchial carcinoma: factors influencing postoperative survival. Br J Dis Chest 1984;78:225-35.
12. Hall S, Holman CD, Sheiner H, Hendrie D. The influence of socioeconomic and locational disadvantage on survival after a diagnosis of lung or breast cancer in Western Australia. J Health Serv Res Policy 2004;9 suppl 2:10-6.
13. Silverstein MD, Nietert PJ, Ye X, Lackland DT. Access to care and stage at diagnosis for patients with lung and esophageal cancer: analysis of the Savannah River Region Information System cancer registry data. South Med J 2002;95:900-8.
14. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer 2001;84:910-4.
15. Holzman D. Better access for the poor may improve lung cancer survival. J Natl Cancer Inst 1995;87:1212.
16. McDavid K, Tucker TC, Sloggett A, Coleman MP. Cancer survival in Kentucky and health insurance coverage. Arch Intern Med 2003;163:2135-44.
17. Fergusson RJ, Thomson CS, Brewster DH, Brown PH, Milroy R. Scottish Cancer Trials Group, Scottish Cancer Therapy Network. Lung cancer: the importance of seeing a respiratory physician. Eur Respir J 2003;21:606-10.
18. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20,561. Ann Oncol 2002;13:1087-93.
19. Blackstock AW, Herndon JE, II, Paskett ED, et al. Outcomes among African-American/non-African-American patients with advanced non-small cell lung carcinoma: report from the Cancer and Leukemia Group B. J Natl Cancer Inst 2002;94:284-90.
20. Visbal, et al. Gender difference in non-small cell lung cancer survival: an analysis of 4618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-15.
21. Mackillop WJ, Zhang-Salomons J, Paszat L, Holowaty E. Socioeconomic status and cancer survival in Ontario. J Clin Oncol 1997;15:1680-9.
22. Jack RH, Gulliford MC, Ferguson J, Moller H. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to Oncology services? Br J Cancer 2003;88:1025-31.
23. Janssen-Heijnen ML, Gatta G, Forman D, Capocaccia R, Coebergh JW. Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer 1998;34:2191-6.
24. Martin B, Paemans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer 2004;91:2018-25.
25. Lu C, Soria JC, Tang X, et al. Prognostic factors in resected stag I non-small cell lung cancer: a multivariant analysis of six molecular markers. J Clin Oncol 2004;22:4575-83.
26. Swinson DE, Jones JL, Cox G, Richardson D, Harris AL, O'Byrne KJ. Hypoxia-inducible factor-1 alpha in non-small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 2004;111:43-50.
27. Onn A, Correa AM, Gilcrease M, et al. Synchronous over expression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 2004;10:136-43.
28. Marrogi AJ, Travis WD, Welsh JA, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 2000;6:4739-44.
29. Ambrosone CB, Rao U, Michalek AM, Cummings KM, Mettlin CJ. Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer. Cancer 1993;72:1192-8.
30. Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH. Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 2000;152:497-50.
31. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risks in families of non-smoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 1999;17:253-73.
32. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients age race-ethnicity, gender, and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol 2004;57:597-609.
33. Fujisawa T, Iizasa T, Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small cell lung carcinomas. J Clin Oncol 1999;17:2086-91.
34. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-51.
35. Okada M, Nishio W, Sakamoto T, et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: an analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004;78:216-21.
36. Konaka C, Ikeda N, Toshhimiysu H, et al. Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathogic presentation. Lung Cancer 1998;21:185-91.
37. Garja A, Newman N, Gamble GP, Abraham ZA, Kohman LJ, Graziano SL. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003;42:51-7.